­­CMP ​​​​​​​Pharma debuts Liqrev

Liqrev is indicated for the treatment of pulmonary arterial hypertension in adults to improve exercise ability and delay clinical worsening.
Sandra Levy
Senior Editor
Levy
liqrev-bottle

CMP Pharma is offering Liqrev (sildenafil) oral suspension, 10 mg/ml, the only FDA-approved ready-made oral liquid of sildenafil.

Liqrev is formulated for patients with dysphagia or difficulty swallowing tablets. Liqrev is indicated for the treatment of pulmonary arterial hypertension to improve exercise ability and delay clinical worsening.

Liqrev addresses the inconsistencies that come from unapproved crushed or compounded tablets and removes the need for complex preparation of powder formulations. Liqrev has a strawberry flavor and is available in 122 ml bottles with a 24-month shelf life, the company noted.

[Read more: Dr. Reddy's launches generic Remodulin]

"Liqrev is for patients who need a liquid formulation because they have difficulty swallowing tablets," said Gerald Sakowski, CEO of CMP Pharma. "This product is a nice addition to our portfolio of liquids for patients with pulmonary arterial hypertension."

[Read more: Camber debuts generic Revatio OS]

Liqrev is available through three preferred specialty pharmacies and selected wholesalers. 

X
This ad will auto-close in 10 seconds